Pages that link to "Q45000191"

The following pages link to The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man (Q45000191):

Displaying 39 items.

• The Treatment of Common Cardiac Arrhythmias (Q34080356) (← links)
• Drug structure-transport relationships (Q34420259) (← links)
• Physiological and pharmacological variability in estimated hepatic blood flow in man. (Q34448582) (← links)
• Lignocaine kinetics in cardiac patients and aged subjects (Q34515754) (← links)
• Altered Hepatic Blood Flow and Drug Disposition1 (Q35372340) (← links)
• Tumescent technique for regional anesthesia permits lidocaine doses of 35 mg/kg for liposuction (Q37906607) (← links)
• Drug disposition in pathophysiological conditions (Q38022659) (← links)
• Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide (Q38240990) (← links)
• Drug Kinetics and Artificial Kidneys1 (Q39174913) (← links)
• Drug Metabolism under Pathological and Abnormal Physiological States in Animals and Man (Q39620103) (← links)
• Hepatic Vasculature: A Conceptual Review (Q39694307) (← links)
• The hepatic artery: Subservient to hepatic metabolism or guardian of normal hepatic clearance rates of humoral substances (Q39714515) (← links)
• Rational Basis of Antiarrhythmic Therapy: Clinical Pharmacology of Commonly Used Antiarrhythmic Drugs (Q39722587) (← links)
• Pulmonary Disease and Drug Kinetics (Q39758582) (← links)
• Lidocaine prophylaxis against ventricular fibrillation in acute myocardial infarction (Q39786917) (← links)
• Drug Kinetics and Hepatic Blood Flow (Q39842386) (← links)
• Measurement of Therapeutic Agents in Blood (Q39935532) (← links)
• Individualization of Dosage of Antiarrhythmic Drugs (Q39947947) (← links)
• Salivary Antipyrine Kinetics in Hepatic and Renal Disease and in Patients on Anticonvulsant Therapy (Q40511110) (← links)
• Complications of chronic liver disease. (Q40549294) (← links)
• Atrioventricular block with lidocaine therapy (Q42234328) (← links)
• Sinus bradycardia due to lidocaine: Clinical-electrophysiologic correlations (Q42235626) (← links)
• Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program (Q43585383) (← links)
• Gompertz pharmacokinetic model for drug disposition (Q44008105) (← links)
• Pharmacokinetics of diazepam in disordered liver function (Q44391949) (← links)
• Hepatic blood flow in acute myocardial ischemia (Q44393367) (← links)
• Lidocaine: To Taper or not to Taper? (Q44462833) (← links)
• Clearance of antipyrine-dependence of quantitative liver function (Q47864473) (← links)
• Effect of the hour of administration on the pharmacokinetics of lidocaine in the rat. (Q51852976) (← links)
• Extracorporeal pump assistance--novel treatment for acute lidocaine poisoning (Q51863517) (← links)
• Lidocaine plasma concentrations obtained with a standardized infusion in the awake and anaesthetized dog. (Q51867214) (← links)
• Lidocaine toxicity (Q51871776) (← links)
• Extraction and Metabolism of Lidocaine in Rat Liver (Q52710264) (← links)
• Logical approach to lignocaine therapy. (Q52713526) (← links)
• Gross impairment of hepatic drug metabolism in a patient with chronic liver disease. (Q52720486) (← links)
• Effect of lidocaine on the scalar orthogonal electrocardiogram (Q52733251) (← links)
• Pharmacokinetics in liver disease (Q68156890) (← links)
• Acute toxicity of local anesthetics as a function of the patient's condition (Q68481495) (← links)
• Modelling of individual pharmacokinetics for computer-aided drug dosage (Q69384731) (← links)